BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

講師

酷氏基因生物科技股份有限公司

 

Company Info

Name /Guzip Biomarkers Corporation

Address /4F., No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302041, Taiwan (R.O.C.)

Website /http://www.guzipbio.com/en/about-guzip/

Presenter

Name /Polly Lin

Title /CEO

Email /pollylin@guzipbio.com

Telephone /+886-3-578-1168 #30108

Fax /+886-3-578-5099

Mobile /0910390169

Company Type

Biotechnology

About the Company

Guzip Biomarkers Corporation (Guzip), a Taiwan startup established in 2018, is specialized at providing novel DNA methylation epigenetic biomarkers for applications in the clinic. Our company vision is to create a better and healthier day for woman and girls, providing accurate, affordable, and safe medical solutions to women.

Brief Description of main products or services

MPapⓇ test

Our first product, MPap test, is an innovative molecular diagnostic test that can be used for endometrial cancer.

The MPap test as an auxiliary test for Endometrial Cancer qualitatively detects the methylation status of BHLHE22 and CDO1 genes with Methylation-Specific qPCR (MSP) technology. The test results provide doctors a reference to evaluate how susceptible a woman with abnormal uterine bleeding (AUB), aged >40 or postmenopausal, is to EC, for the justification of whether an invasive endometrial diagnostic procedure (IVP) or conservative treatment to proceed.

Other product pipeline

Guzip also develops the methylation biomarkers for upper urinary tract urothelial carcinoma (UTUC), and predicting biomarkers for the endometrial receptivity during in vitro fertilization (IVF) process.

Contact Person

Name /Polly Lin

Email /pollylin@guzipbio.com

Phone /+886-3-578-1168 #30108